News
The mHealth Summit session "Using Mobile Anytime, Anywhere" takes a look at how visiting nurses are incorporating tablets, social media and remote video in their work.
New ventures should consider a "regulatory plan" just as carefully as the rest of their "business plan."
The three-month program aims to determine if a smartphone app can help cancer patients improve their chemotherapy adherence and ultimately bolster clinical outcomes.
With so many mobile vendors rushing to market diabetes applications and devices, will the lessons they learn translate to better mHealth products across the board?
23andme has been ordered to stop marketing its $99 DNA testing kits until its medical claims can be verified and the device receives FDA clearance.
The fastest demographic coming online has shown great interest in using mobile technologies, but most are still finding a lack of available options for doing so.